On Invalid Date, Abbvie (NYSE: ABBV) reported Q1 2024 earnings per share (EPS) of $0.77, up 492.31% year over year. Total Abbvie earnings for the quarter were $1.37 billion. In the same quarter last year, Abbvie's earnings per share (EPS) was $0.13.
As of Q2 2024, Abbvie's earnings has grown -20.89% year over year. This is 40.51 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19.62%. Abbvie's earnings in the past year totalled $5.99 billion.
What was ABBV's revenue last quarter?
On Invalid Date, Abbvie (NYSE: ABBV) reported Q1 2024 revenue of $12.31 billion up 0.7% year over year. In the same quarter last year, Abbvie's revenue was $12.23 billion.
What was ABBV's revenue growth in the past year?
As of Q2 2024, Abbvie's revenue has grown -4.12% year over year. This is 12.97 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.85%. Abbvie's revenue in the past year totalled $54.40 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.